LA Private

October 9, 2023

Stocks of the Hour: Radiopharm Theranostics, Talon Energy, Azure Minerals

Radiopharm Theranostics (ASX:RAD) announced it has been granted Human Research Ethics Committee approval to commence its First-In-Human Phase I study in Australia for the Company’s therapy for patients with PDL1- positive non-small cell lung cancer. The trial is expected to start shortly. Shares are trading flat at 13 cents. Talon Energy (ASX:TPD) announced an update

Stocks of the Hour: Radiopharm Theranostics, Talon Energy, Azure Minerals Read More »